adamantane has been researched along with Aura in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Amakhin, DV; Chizhov, AV; Soboleva, EB; Zaitsev, AV | 1 |
| Beck, H; Müller-Komorowska, D; Opitz, T; Pothmann, L; Schmidt, S; Soares da Silva, P | 1 |
| Amato, GS; Burns, JF; Eargle, CW; Fritch, PC; Harrison, W; Jones, L; McNaughton-Smith, G; Roeloffs, R; Wickenden, AD | 1 |
3 other study(ies) available for adamantane and Aura
| Article | Year |
|---|---|
Insertion of Calcium-Permeable AMPA Receptors during Epileptiform Activity In Vitro Modulates Excitability of Principal Neurons in the Rat Entorhinal Cortex.
Topics: Adamantane; Animals; Calcium; Computer Simulation; Dizocilpine Maleate; Entorhinal Cortex; Epilepsy; GABA-B Receptor Antagonists; In Vitro Techniques; Male; Membranes; Models, Theoretical; Neurons; Patch-Clamp Techniques; Phosphinic Acids; Propanolamines; Rats, Wistar; Receptors, AMPA; Receptors, GABA-B; Receptors, N-Methyl-D-Aspartate | 2021 |
Complex effects of eslicarbazepine on inhibitory micro networks in chronic experimental epilepsy.
Topics: Adamantane; Animals; Anticonvulsants; CA1 Region, Hippocampal; Calcium; Dibenzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Feedback, Physiological; Hippocampus; Inhibitory Postsynaptic Potentials; Interneurons; Long-Term Potentiation; Muscarinic Agonists; Neural Inhibition; Neuronal Plasticity; Neurons; Pilocarpine; Pyramidal Cells; Rats; Receptors, AMPA | 2021 |
Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.
Topics: Adamantane; Animals; Azides; Epilepsy; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Mice; Neuralgia; Structure-Activity Relationship | 2010 |